These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Kaposi's sarcoma of the laryngopharynx]. Zenger VG; Synebogov SV; Kadyrova EV Vestn Otorinolaringol; 2002; (5):48-9. PubMed ID: 12524971 [No Abstract] [Full Text] [Related]
6. [Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine]. Gorshkova NI; Samsonov VA; Mazina NM; Parastaev SA Vestn Dermatol Venerol; 1989; (9):6-10. PubMed ID: 2609769 [TBL] [Abstract][Full Text] [Related]
7. [The use of cytostatic preparations in treating Kaposi's sarcoma by encircling injections]. Shakhnes IE Vestn Dermatol Venerol; 1988; (11):28-9. PubMed ID: 3239226 [No Abstract] [Full Text] [Related]
8. [Lesion of the mouth mucosa in Kaposi's sarcoma]. Stoianov VB Vestn Dermatol Venerol; 1978 Nov; (11):74-7. PubMed ID: 735347 [No Abstract] [Full Text] [Related]
9. [Visceral lesions in Kaposi angioreticulosis and effect of prospidine therapy]. Shaposhnikova OK; Rodionov AN Vestn Dermatol Venerol; 1977 Jul; (7):49-52. PubMed ID: 899237 [No Abstract] [Full Text] [Related]
10. [Prospidin in combination with gamma teletherapy in treating esophageal cancer]. Kusherbaev SK; Filippenko VI; Turganbaeva DA; Urbisinov ZhK Med Radiol (Mosk); 1979 May; 24(5):21-6. PubMed ID: 374920 [No Abstract] [Full Text] [Related]
12. [Clinico-morphological characteristics of mycosis fungoides during the treatment with prospidin in combination with corticosteroid hormones]. Tevzadze MSh Vestn Dermatol Venerol; 1982 Apr; (4):10-4. PubMed ID: 7090532 [No Abstract] [Full Text] [Related]
13. [Use of prospidin in the combination chemotherapy of recurrences of generalized forms of lymphogranulomatosis]. Vinokurova NA; Danova LA; Kondrat'ev VB; Gershanovich ML Vopr Onkol; 1983; 29(7):46-50. PubMed ID: 6880132 [TBL] [Abstract][Full Text] [Related]
14. [Kaposi's sarcoma in a female patient taking corticosteroids for a long time]. Vyborov AM; Romanenko GF Vestn Dermatol Venerol; 1989; (1):48-9. PubMed ID: 2718617 [TBL] [Abstract][Full Text] [Related]
15. [The effect of 11-deoxycortiocosterone acetate on the antitumor activity of prospidin]. Kravchenko AI; Chernov VA Vopr Onkol; 1975; 21(12):33-7. PubMed ID: 1210128 [TBL] [Abstract][Full Text] [Related]
16. [The effectiveness of treating patients with malignant skin lymphoma and Kaposi's sarcoma studied via polyamines]. Faradzhev ZG; Samsonov VA; Bassalyk LS; Nemtsova MP Vestn Dermatol Venerol; 1989; (11):20-5. PubMed ID: 2618159 [TBL] [Abstract][Full Text] [Related]
17. [Prospidin cream in the treatment of pointed condylomata acuminata]. El'kin VD; Datskovskiĭ SB; Rudakova RA Urol Nefrol (Mosk); 1982; (4):62-3. PubMed ID: 7135694 [No Abstract] [Full Text] [Related]
18. Treatment of Kaposi's sarcoma with ICRF-159 (NSC-129943). Olweny CL; Masaba JP; Sikyewunda W; Toya T Cancer Treat Rep; 1976 Jan; 60(1):111-3. PubMed ID: 1000514 [No Abstract] [Full Text] [Related]
19. [A new basic drug prospidin in the treatment of rheumatoid arthritis. III. Comparative analysis of prospidin and cyclophosphamide]. Benenson EV; Nemtsov BF; Ualieva TM Ter Arkh; 1987; 59(4):76-9. PubMed ID: 3035735 [TBL] [Abstract][Full Text] [Related]
20. [Clinico-pharmacological study of prospidin]. Perevodchikova NI; Lichinitser MR; Akyshbaev AA; Averinova SG; Bassalyk LS Vopr Onkol; 1983; 29(2):51-6. PubMed ID: 6188275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]